A drug delivery system obtained by hot-melt processing of zein plasticized by a pharmaceutically active ionic liquid. Issue 21 (11th May 2020)

• Record Type: Journal Article
• Authors: Chaunier, Laurent; Viau, Lydie; Falourd, Xavier; Lourdin, Denis; Leroy, Eric
• Is Part Of: Journal of materials chemistry. Volume 8:Issue 21(2020)
• Page Start: 4672
• Page End: 4679
• Publication Date: 2020-05-11
• Subjects: Materials -- Periodicals; Chemistry, Analytic -- Periodicals; Biomedical materials -- Research -- Periodicals; 543.0284
• DOI: 10.1039/d0tb00326c
• Languages: English
• ISSNs: 2050-750X

Abstract

Abstract : Zein is extruded with [Lidocainium][Ibuprofenate] to obtain an amorphous drug delivery system. Abstract : Zein-based filaments containing 20 weight% [Lidocainium][Ibuprofenate] used as a doubly Active Pharmaceutical Ingredient–Ionic Liquid (API–IL) were obtained by extrusion at 130 °C. The plasticizing effect of the active ingredient on the zein amorphous matrix was assessed by differential scanning calorimetry, with a decrease in the glass transition temperature ( T g ) from 77 °C, for the raw zein, to 53 °C. After storage under standard conditions (relative humidity 59%, 20 °C) the extrudates were rigid, with a high storage modulus ( E ′) of about 3 GPa at ambient temperature. They had a main mechanical relaxation ( T α ) beginning at 55 °C, leading to their flowing at temperatures above 130 °C, as determined by dynamic mechanical analysis, with E ′ below 1 MPa and tan δ above 1. Their structure was evaluated by wide angle X-ray scattering and NMR analysis was used to evaluate the API–IL stability after thermomechanical processing. Release experiments performed under simulated physiological conditions on filaments evidenced a release of 85% after 7 days immersion. These results demonstrate the advantage of using an API–IL as plasticizer of a resorbable biopolymer. The resulting material can be shaped by a continuous thermomechanical process and used as a drug delivery system.